T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial (Q34524948)

2 August 2017

T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial (English)

1 reference

double-blind clinical trial

2 August 2017

0 references

1 reference

Massimo Filippi

9

0 references

Irun Cohen

17

object named as

Irun R Cohen

1 reference

2 August 2017

Dimitrios Karussis

1

1 reference

2 August 2017

Hagai Shor

2

1 reference

2 August 2017

Julia Yachnin

3

1 reference

2 August 2017

Naama Lanxner

4

1 reference

2 August 2017

Merav Amiel

5

1 reference

2 August 2017

Keren Baruch

6

1 reference

2 August 2017

Yael Keren-Zur

7

1 reference

2 August 2017

Ofra Haviv

8

1 reference

2 August 2017

Panayiota Petrou

10

1 reference

2 August 2017

Shalom Hajag

11

1 reference

2 August 2017

Urania Vourka-Karussis

12

1 reference

2 August 2017

Adi Vaknin-Dembinsky

13

1 reference

2 August 2017

Salim Khoury

14

1 reference

2 August 2017

Oded Abramsky

15

1 reference

2 August 2017

Henri Atlan

16

1 reference

2 August 2017

Rivka Abulafia-Lapid

18

1 reference

2 August 2017

language of work or name

English

0 references

publication date

14 December 2012

1 reference

2 August 2017

1 reference

2 August 2017

7

1 reference

2 August 2017

e50478

1 reference

2 August 2017

12

1 reference

Creative Commons Attribution 4.0 International

2 August 2017

start time

14 December 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

HSP60 as a target of anti-ergotypic regulatory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522721

Autologous T-cell vaccination for multiple sclerosis: a perspective on progress

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522721

Anti-ergotypic immunoregulation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522721

CD4+ regulatory T cell responses induced by T cell vaccination in patients with multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522721

Regulatory T cells in autoimmune diseases: anti-ergotypic T cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522721

T-cell vaccination in multiple sclerosis: update on clinical application and mode of action

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522721

Insights into the immunopathogenesis of multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522721

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadi

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522721

T cell vaccination in secondary progressive multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522721

Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522721

Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522721

T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522721

Vaccination with autoreactive T cell clones in multiple sclerosis: overview of immunological and clinical data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522721

MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522721

Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses.

7 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0050478

T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0050478

T cell vaccination in multiple sclerosis: results of a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0050478

Specificity of regulatory CD4+CD25+ T cells for self-T cell receptor determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0050478

Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0050478

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0050478

Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0050478

Myelin reactive T cells after T cell vaccination in multiple sclerosis: cytokine profile and depletion by additional immunizations

21 January 2018

1 reference

12 December 2020

Multiple sclerosis: a two-stage disease

1 reference

12 December 2020

Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis

1 reference

12 December 2020

Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0050478

Identifiers

DOI

1 reference

2 August 2017

0 references

1 reference

2 August 2017

1 reference